MAPK inhibition and growth hormone: a promising therapy in XLH.
Fuente R, Gil-Peña H, Claramunt-Taberner D, Hernández-Frías O, Fernández-Iglesias Á, Alonso-Durán L, Rodríguez-Rubio E, Hermida-Prado F, Anes-González G, Rubio-Aliaga I, Wagner C, Santos F.
Fuente R, et al.
FASEB J. 2019 Jul;33(7):8349-8362. doi: 10.1096/fj.201802007R. Epub 2019 Apr 11.
FASEB J. 2019.
PMID: 30974062
Thus, the growth-promoting effect of GH is likely linked to increased risk of bone deformities, whereas the association of GH and MAPK inhibition emerges as a promising new therapy for children with XLH.-Fuente, R., Gil-Pena, H., Claramunt-Taberner, D., Hernandez-Fr …
Thus, the growth-promoting effect of GH is likely linked to increased risk of bone deformities, whereas the association of GH and MAPK inhib …